Pharmacology & Toxicology Webinars
Page 1 of 10
APS Physiology in Disease Modeling and Drug Development Roundtable
Tuesday, January 24, 2023
Sponsor: Cytokinetics
Partner: American Physiological Society
Key opinion leaders in cardiovascular physiology and bioengineering discuss best practices and challenges when modeling cardiomyopathies and other cardiovascular diseases using stem cells, engineered tissues and other novel platforms.
The 3D DILI Model of Success – from Biological Relevance to Industry Application
Tuesday, January 24, 2023
Sponsor: InSphero
Dr. Anna Borgström and Dr. Frauke Greve present the latest advancements in hepatic safety assessment using 3D liver spheroids.
Essential Bruker NMR Trainings 2023
Webinar Series
January - June 2023
Upcoming
Join Bruker experts for 1-hour every other week online for this essential training program designed for NMR Scientists.
It’s Life, but Not As We Know It: How Predictive Human Organ Models Are Transforming and Reshaping the Efficiency of Drug Discovery
Tuesday, December 6, 2022
Sponsor: CN Bio
Partner: Scientist.com
Dr. Audrey Dubourg and Dr. Gareth Guenigault explore the value that an organ-on-a-chip approach can bring to drug discovery and development workflows, and how the regulatory landscape is shifting to encourage their widespread adoption.
Rethink your Impurity Analysis Strategy
Tuesday, November 15, 2022
Sponsor: Alphalyse
Partner: Scientist.com
In this webinar, Dr. Ejvind Mørtz discusses the benefits and applications of mass spectrometry (MS)-based host cell protein (HCP) analysis and why HCP ELISAs are insufficient for documenting product-related impurities. Watch to learn where to apply the assay in a typical process and what you gain from deploying it to your workflow.
Creating Better Gene-Edited Cell Lines with the FAST-HDR System
Wednesday, October 26, 2022
Sponsor: ExpressCells
Dr. Oscar Perez and Dr. Jon Weidanz discuss the basis of the FAST-HDR gene-editing system and present case studies highlighting several applications.
Are In Vitro Metabolism and Drug-Drug Interaction Studies Critical for an Investigational New Drug Application?
Tuesday, October 25, 2022
Sponsor: XenoTech
Partner: Scientist.com
Andrew G. Taylor, PhD provides an overview of processes by which drugs are metabolized and discusses the importance of drug metabolism and drug-drug interaction studies.
Intestinal Toxicity Assessment with Patient-Derived Organoids
Thursday, September 15, 2022
Sponsor: STEMCELL Technologies Inc.
Partner: Scientist.com
Dr. Martin Stahl describes the use of patient-derived intestinal organoids to assess the toxicity of potential therapeutic compounds and study barrier function in a human-specific model system.
Integration of the HTG Transcriptome Panel into Preclinical and Clinical Programs to Drive Precision Medicine Research
Thursday, June 23, 2022
Sponsor: HTG Molecular Diagnostics, Inc.
Partner: Scientist.com
Dr. Peter Ansell discusses the use of novel RNA-based gene expression profiling methods for clinical and preclinical oncology research.
A Novel, All-Human Hepatic Triculture System
Thursday, May 19, 2022
Sponsor: LifeNet Health LifeSciences
Partner: Scientist.com
Join Edward LeCluyse and Paul Gallant as they offer insight into a novel, all-human hepatic triculture and how this unique system addresses the need for a convenient and human-relevant long-term hepatic culture.
The Variant-Rich Biobank: An Insider’s Look
Thursday, March 31, 2022
Sponsor: Precision for Medicine
Partner: Scientist.com
Experts provide a showcase of Precision for Medicine’s variant-rich biobank. including discussion on biospecimen types, applications, screening methods, and support for companion diagnostic development.
Current and Novel Immuno-Oncology Drug Evaluation Methods via Humanized Mouse Models
Thursday, March 24, 2022
Sponsor: Shanghai Lide Biotech Co., Ltd. (Lide Biotech)
Partner: Scientist.com
Dr. Bin Xie discusses the current immuno-oncology drug development landscape, different humanized mouse models available for drug testing, and the investigation of potential mechanisms via imaging mass cytometry.
Page 1 of 10